COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection
Public ClinicalTrials.gov record NCT04666441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to assess the virologic efficacy of REGN10933+REGN10987 across different intravenous and subcutaneous doses compared to placebo. The secondary objectives of the study are: * To evaluate additional indicators of virologic efficacy of REGN10933+REGN10987 compared to placebo * To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo * To assess the concentrations of REGN10933 and REGN10987 in serum over time * To assess the immunogenicity of REGN10933 and REGN10987
Study identification
- NCT ID
- NCT04666441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,149 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2020
- Primary completion
- Mar 3, 2021
- Completion
- Sep 20, 2021
- Last update posted
- Apr 7, 2022
2020 – 2021
United States locations
- U.S. sites
- 57
- U.S. states
- 19
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Regeneron Study Site | Mesa | Arizona | 85210 | — |
| Regeneron Study Site | Tucson | Arizona | 85712 | — |
| Regeneron Study Site | Canoga Park | California | 91303 | — |
| Regeneron Study Site | Long Beach | California | 90806 | — |
| Regeneron Study Site | Los Angeles | California | 90036 | — |
| Regeneron Study Site | Rolling Hills Estates | California | 90274 | — |
| Regeneron Study Site | San Francisco | California | 94127 | — |
| Regeneron Study Site | Santa Monica | California | 90404 | — |
| Regeneron Study Site | Stanford | California | 94305 | — |
| Regeneron Study Site | Colorado Springs | Colorado | 80907 | — |
| Regeneron Study Site | Washington D.C. | District of Columbia | 20037 | — |
| Regeneron Study Site | DeLand | Florida | 32720 | — |
| Regeneron Study Site | Ft. Pierce | Florida | 34982 | — |
| Regeneron Study Site | Hialeah | Florida | 33010 | — |
| Regeneron Study Site | Hialeah | Florida | 33012 | — |
| Regeneron Study Site | Maitland | Florida | 32751 | — |
| Regeneron Study Site | Miami | Florida | 33126 | — |
| Regeneron Study Site | Miami | Florida | 33184 | — |
| Regeneron Study Site | St. Petersburg | Florida | 33705 | — |
| Regeneron Study Site | Tampa | Florida | 33606 | — |
| Regeneron Study Site | West Palm Beach | Florida | 33407 | — |
| Regeneron Study Site | Winter Haven | Florida | 33880 | — |
| Regeneron Study Site | Winter Park | Florida | 32789 | — |
| Regeneron Study Site | Atlanta | Georgia | 30322 | — |
| Regeneron Study Site | Columbus | Georgia | 31904 | — |
| Regeneron Study Site | Downers Grove | Illinois | 60515 | — |
| Regeneron Study Site | Ames | Iowa | 50010-3014 | — |
| Regeneron Study Site | Iowa City | Iowa | 52242 | — |
| Regeneron Study Site | Lake Charles | Louisiana | 70601 | — |
| Regeneron Study Site | Marrero | Louisiana | 70072 | — |
| Regeneron Study Site | Shreveport | Louisiana | 71118 | — |
| Regeneron Study Site | Baltimore | Maryland | 21201 | — |
| Regeneron Study Site | Las Vegas | Nevada | 89109 | — |
| Regeneron Study Site | Teaneck | New Jersey | 07666 | — |
| Regeneron Study Site | New York | New York | 10037 | — |
| Regeneron Study Site | The Bronx | New York | 10451 | — |
| Regeneron Study Site | Charlotte | North Carolina | 28209 | — |
| Regeneron Study Site | Durham | North Carolina | 27705 | — |
| Regeneron Study Site | Wilmington | North Carolina | 28401 | — |
| Regeneron Study Site | Columbus | Ohio | 43215 | — |
| Regeneron Study Site | Dayton | Ohio | 45409 | — |
| Regeneron Study Site | Dayton | Ohio | 45432 | — |
| Regeneron Study Site | Philadelphia | Pennsylvania | 19140 | — |
| Regeneron Study Site | Charleston | South Carolina | 29425 | — |
| Regeneron Study Site | Clinton | South Carolina | 29325 | — |
| Regeneron Study Site | Amarillo | Texas | 79109 | — |
| Regeneron Study Site | Corpus Christi | Texas | 78413 | — |
| Regeneron Study Site | Houston | Texas | 77008 | — |
| Regeneron Study Site | Houston | Texas | 77030 | — |
| Regeneron Study Site | Houston | Texas | 77057 | — |
| Regeneron Study Site | Houston | Texas | 77093 | — |
| Regeneron Study Site | Pearland | Texas | 77584 | — |
| Regeneron Study Site | Red Oak | Texas | 75154 | — |
| Regeneron Study Site | San Antonio | Texas | 78249 | — |
| Regeneron Study Site | Splendora | Texas | 77372 | — |
| Regeneron Study Site | Tyler | Texas | 75701 | — |
| Regeneron Study Site | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04666441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2022 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04666441 live on ClinicalTrials.gov.